SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-23-043104
Filing Date
2023-05-25
Accepted
2023-05-25 16:31:17
Documents
62
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2022a1_raphaelpharma.htm   iXBRL 10-K/A 493273
2 CERTIFICATION f10k2022a1ex31-1_raphael.htm EX-31.1 8138
3 CERTIFICATION f10k2022a1ex31-2_raphael.htm EX-31.2 8039
4 CERTIFICATION f10k2022a1ex32-1_raphael.htm EX-32.1 3288
5 CERTIFICATION f10k2022a1ex32-2_raphael.htm EX-32.2 3318
6 GRAPHIC image_001.jpg GRAPHIC 6834
7 GRAPHIC image_002.jpg GRAPHIC 1408
8 GRAPHIC image_003.jpg GRAPHIC 3892
  Complete submission text file 0001213900-23-043104.txt   3220234

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE cik0000141539-20221231.xsd EX-101.SCH 52154
10 XBRL CALCULATION FILE cik0000141539-20221231_cal.xml EX-101.CAL 16982
11 XBRL DEFINITION FILE cik0000141539-20221231_def.xml EX-101.DEF 163946
12 XBRL LABEL FILE cik0000141539-20221231_lab.xml EX-101.LAB 351360
13 XBRL PRESENTATION FILE cik0000141539-20221231_pre.xml EX-101.PRE 170185
56 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022a1_raphaelpharma_htm.xml XML 310166
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

IRS No.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-53002 | Film No.: 23961231
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences